Table 1.
CON group (n = 10) | EX group (n = 20) | |
---|---|---|
Age, years, median (IQR) | 68 (61; 70) | 63 (57; 67) |
Gleason score, n/N (%) | ||
<7 | 2/10 | 6/20 (30) |
7 | 6/10 | 12/20 (60) |
>7 | 2/10 | 2/20 (10) |
PSA level, μg/L, median (IQR) | 9.1 (8.4; 18.0) | 7.4 (5.4; 13.0) |
Body composition | ||
BMI, kg/m2, median (IQR) | 27 (24; 30) | 27 (25; 29) |
Total fat percentage, mean (SD) | 28.5 (6.7) | 29.3 (6.1) |
Total fat mass, kg, mean (SD) | 23.6 (8.0) | 24.4 (6.1) |
Android fat mass, kg, mean (SD) | 2.8 (1.2) | 2.8 (0.9) |
Gynoid fat mass, kg, mean (SD) | 3.6 (1.0) | 3.6 (0.8) |
Lean body mass, kg, mean (SD) | 57.3 (6.4) | 58.3 (5.9) |
Smoker, n (%) | ||
Never | 5/10 | 9/20 (45) |
Previous | 3/10 | 9/20 (45) |
Current | 2/10 | 2/20 (10) |
Alcohol intake (units/week), n (%) | ||
≤14 | 9/10 | 16/20 (80) |
>14 | 1/10 | 4/20 (20) |
Physical activity level (min MVPA/week), n (%) | ||
<150 min | 3/10 | 2/20 (10) |
≥150 min | 7/10 | 18/20 (90) |
Cardiorespiratory fitness* | ||
VO2peak, L/min, mean (SD) | 2.62 (0.59) | 2.89 (0.50) |
VO2peak, mL/min/kg, mean (SD) | 31.4 (8.4) | 33.6 (6.3) |
NK cell infiltration, mean (SD) | ||
NK cells/mm2, tumour tissue | 1.05 (1.37) | 1.51 (1.85) |
NK cells/mm2, healthy tissue | 4.15 (4.50) | 2.37 (3.33) |
Values are presented as mean (SD), median (IQR [Q1; Q3]), or n/N (%).
BMI, body mass index; MVPA, moderate to vigorous physical activity.
Cardiorespiratory fitness data are based on cardiorespiratory tests meeting two of the following test criteria: respiratory exchange ratio (RER) ≥1.10, rate of perceived exertion (RPE) ≥18, and a VO2 plateau (EX, n = 18; CON, n = 8).